Holen Sie sich die Stockscreener-App
203.83
2.66%
5.29
Vorhandelsmarkt:
205.22
1.39
+0.68%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DVA?
Forum
Prognose
Aktiensplit
Davita Inc Aktie (DVA) Neueste Nachrichten
DaVita, SCA, USPI defeat class certification bid in US no-poach litigation - MLex
DaVita HealthCare (DVA) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
DaVita HealthCare (DVA) Moves to Strong Buy: Rationale Behind the Upgrade - Yahoo Finance
DaVita expands comprehensive kidney care through dialysis services - MSN
DaVita stock gains from integrated kidney care and CKCC progress - MSN
DaVita Stock Gains From Integrated Kidney Care and CKCC Progress - TradingView
Are Investors Undervaluing DaVita (DVA) Right Now? - Yahoo Finance
Zacks Industry Outlook Highlights Quest Diagnostics, DaVita, LifeStance Health and Aveanna Healthcare - Yahoo Finance
DaVita’s US$500 Million Term Loan Reshapes Debt And Liquidity Profile - Yahoo Finance
DaVita Inc. $DVA Stake Lifted by Los Angeles Capital Management LLC - MarketBeat
A Look at DaVita Inc (DVA) After 3.2% Gain -- GF Value $172.98 v - GuruFocus
DaVita Expands Term Loan Facility, Enhancing Capital Flexibility - The Globe and Mail
Best Growth Stocks to Buy for June 9th - Yahoo! Finance Canada
Best Value Stocks to Buy for June 9th - Yahoo Finance Singapore
DaVita Inc. (DVA) Announces Ninth Amendment to Credit Agreement - GuruFocus
DavitaEnters Ninth Amendment To Credit Agreement With Jpmorgan On June 8, 2026SEC Filing - TradingView
DaVita Secures $500 Million Incremental Term Loan B-2 Under Credit Facility With JPMorgan - TradingView
DaVita Inc. Enters into Ninth Amendment to Credit Agreement for $500 Million Incremental Tranche B-2 Term Loan - marketscreener.com
DaVita Inc. (DVA) Maintains Strong Buy Rating for 120 Days - GuruFocus
MOTheR Trial: Advancing Middle-Molecule Clearance - DaVita Newsroom
Bull of the day: DaVita Inc. (DVA) - MSN
Asset turnover of DaVita Inc. – XETR:TRL - TradingView
Cash per share of DaVita Inc. – XETR:TRL - TradingView
Long term debt to total assets ratio of DaVita Inc. – XETR:TRL - TradingView
EBITDA per share of DaVita Inc. – XETR:TRL - TradingView
DaVita Inc. Cash Flow – XETR:TRL - TradingView
DaVita Inc. Statistics – XETR:TRL - TradingView
Assessing DaVita (DVA) Valuation After Strong Q1 2026 Beat And Upgraded Guidance - Yahoo Finance
Nomura Asset Management Co. Ltd. Sells 16,576 Shares of DaVita Inc. $DVA - MarketBeat
Why is DaVita HealthCare Partners stock surging today? - Investing.com
DaVita Inc stock (US23804L1035): Q1 2026 revenue tops estimates while valuation stays in focus - AD HOC NEWS
BofA raises DaVita stock price target to $145 on Q1 beat - Investing.com
DaVita Q1 2026 Earnings: Outpatient and Specialty Care Sector ReviewNews and Statistics - IndexBox
Q1 Earnings Highs And Lows: DaVita (NYSE:DVA) Vs The Rest Of The Outpatient & Specialty Care Stocks - Yahoo Finance
DaVita (DVA) Short Interest & Short Float | Updated Jun 2026 $DVA - MarketBeat
Why is DaVita HealthCare Partners stock surging today? By Investing.com - Investing.com UK
DaVita Inc. stock underperforms Thursday when compared to competitors - MarketWatch
The Sound of a Second Chance: DaVita Patients Celebrate Receiving Their Kidney Transplant - DaVita Newsroom
DaVita Expands Comprehensive Kidney Care Through Dialysis Services - Yahoo Finance
DaVita HealthCare (DVA) Up 0.6% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Best Growth Stocks to Buy for June 4th - Yahoo Finance Singapore
A Look at DaVita Inc (DVA) After 3.8% Gain -- GF Value $172.69 v - GuruFocus
A Look at DaVita Inc (DVA) After 3.8% Gain -- GF Value $172.69 vs Price $195.03 - GuruFocus
How The DaVita (DVA) Story Is Shifting With New Analyst Targets And Valuation Assumptions - Yahoo Finance
DaVita Gains 21.4% in Three Months: How Should You Play the Stock? - TradingView
What are Wall Street analysts' target price for DaVita stock? - MSN
1 Sector Warren Buffett and Greg Abel Are Largely Ignoring -- and Why Investors Shouldn't - The Motley Fool
DaVita Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
DaVita Inc. stock underperforms Monday when compared to competitors - MarketWatch
DaVita Inc. stock (US23918K1088): NYSE-listed dialysis provider trades around late-May levels as inv - AD HOC NEWS
DaVita Inc. (DVA) Stock Analysis: High Return On Equity Highlights Investment Potential - DirectorsTalk Interviews
DaVita Interactive Trivia: Put your knowledge to the test with these questions - Denver7
DaVita Inc stock (US23804L1035): shares ease near late-May levels - AD HOC NEWS
DaVita Inc. stock (US23918K1088): shares ease while investors watch technical levels after recent ga - AD HOC NEWS
DaVita Inc. stock (US23918K1088): NYSE shares hold steady as investors look toward next earnings dat - AD HOC NEWS
DaVita Inc. stock underperforms Friday when compared to competitors - MarketWatch
DaVita Inc. stock (US23918K1088): shares trade sideways ahead of next earnings as valuation comes in - AD HOC NEWS
Why DaVita HealthCare (DVA) is a Top Momentum Stock for the Long-Term - Yahoo Finance
0.40%
0.94%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):